Johnson & Johnson recalls Johnson’s Baby Powder due to asbestos contamination
On October 18, Johnson & Johnson Consumer Inc. (JJCI) announced that it was initiating a voluntary recall of a single lot of its Johnson’s Baby Powder in response to a U.S. Food and Drug Administration (FDA) test indicating the presence of sub-trace levels of chrysotile asbestos contamination (no greater than 0.00002%) in samples from a single bottle purchased from an online retailer.
The one-lot recall involves approximately 33,000 bottles of Johnson’s Baby Powder, according to The Wall Street Journal.
The recall comes at a vulnerable time for J&J, which has been fighting tens of thousands of lawsuits over its talcum powder, opioid drugs and other products. The stock fell 6.2% on Friday.
Also see:
Johnson & Johnson ordered to pay $417M to ovarian cancer victim, illness caused by baby powder talc
Despite the low levels reported and in full cooperation and collaboration with the FDA, JJCI is initiating this voluntary recall of Lot #22318RB of Johnson’s Baby Powder, from which the tested sample was taken.
In parallel, JJCI has immediately initiated a rigorous, thorough investigation into this matter, and is working with the FDA to determine the integrity of the tested sample, and the validity of the test results.
At this stage of their investigation, JJCI reports that the company:
- Cannot confirm if cross-contamination of the sample caused a false positive.
- Cannot confirm whether the sample was taken from a bottle with an intact seal or whether the sample was prepared in a controlled environment.
- Cannot confirm whether the tested product is authentic or counterfeit.
If you or someone you provide care for owns a bottle of Johnson’s Baby Powder Lot #22318RB, you are advised to discontinue use of the product. For refund information, contact the Johnson & Johnson Consumer Care Center at www.johnsonsbaby.com or by calling +1 (866) 565-2229.
For more on the Johnson & Johnson Baby Powder recall, see the video accompanying this article.
(Source: FDA)
~ Posted by: Richard Webster, Ace News Today / Connect with Richard on Facebook and Twitter